ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Generics must not be imperiled over data protection: Satish Reddy, Chairman, Dr Reddy's Laboratories
Dr Reddy's chairman, Satish Reddy, has raised concerns about compromising India's competitive edge in generics for foreign investments. He stresses the importance of aligning capital with developmental needs and enhancing collaboration between academia and
Announcement as on 02 July 2026

Dr Reddys Share Price Live Updates: Dr. Reddys shows a slight gain in today's trading

Announcement as on 22 June 2026

Dr Reddy's launches oral semaglutide biosimilar Obeda in India
Dr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This innovative treatment offers patients the ease of a once-daily oral dosage, available in various strengths to effective
Announcement as on 20 May 2026

Dr Reddy’s launches oral semaglutide in India
Dr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three tablet strengths for daily use. This launch expands access to advanced diabetes care. Dr Reddys is the second Indian co
Announcement as on 20 May 2026

Dr Reddy's Laboratories Q4 Results: Cons PAT falls 86% YoY to Rs 221 crore, revenue dips 12%; Rs 8 per share dividend announced
Dr Reddy's Laboratories Q4 Results: Dr. Reddy's Laboratories reported a consolidated net profit at Rs 221 crore in the March-ended quarter versus Rs 1,587 crore in the year ago period, an 86% YoY fall.
Announcement as on 12 May 2026

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 14.62
  • 12Day Average: 14.25
  • 20Day Average: 13.87
  • 50Day Average: 13.62
  • 100Day Average: 13.75
  • 150Day Average: 13.77
  • 200Day Average: 13.85

RDY Indicators & signals

Indicator MACD (12,26,9)

14.27, 13.96, 0.26
Indicator MACD is in positive zone

Indicator ADX (14)

3.45, 37.5, 35
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Thu Jul 2026 14.38 14.16 to 14.48 2.79% 0.61 times
01 Wed Jul 2026 13.99 13.95 to 14.43 -3.45% 0.99 times
30 Tue Jun 2026 14.49 14.45 to 14.70 -2.49% 0.94 times
29 Mon Jun 2026 14.86 14.66 to 15.13 -3.38% 1.48 times
26 Fri Jun 2026 15.38 15.30 to 15.67 0.85% 1.03 times
25 Thu Jun 2026 15.25 14.61 to 15.27 4.02% 1.28 times
24 Wed Jun 2026 14.66 14.20 to 14.66 2.45% 0.87 times
23 Tue Jun 2026 14.31 13.80 to 14.31 2.88% 1.15 times
22 Mon Jun 2026 13.91 13.45 to 14.03 4.67% 0.9 times
18 Thu Jun 2026 13.29 13.20 to 13.36 1.06% 0.56 times
17 Wed Jun 2026 13.15 13.08 to 13.32 -1.13% 0.8 times
16 Tue Jun 2026 13.30 13.23 to 13.38 -0.23% 0.45 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top